Timing of NT-pro-BNP sampling for predicting adverse outcome after acute pulmonary embolism.
Klok
Frederikus A
FA
van der Bijl
Noortje
N
Mos
Inge C M
IC
de Roos
Albert
A
Kroft
Lucia J M
LJ
Huisman
Menno V
MV
D000368:Aged; D015415:Biomarkers / Q000097:blood; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D032383:Myocytes, Cardiac / Q000378:metabolism* / Q000473:pathology; D020097:Natriuretic Peptide, Brain / Q000096:biosynthesis* / Q000097:blood / Q000235:genetics; D010446:Peptide Fragments / Q000096:biosynthesis* / Q000097:blood / Q000235:genetics; D011379:Prognosis; D011655:Pulmonary Embolism / Q000097:blood / Q000175:diagnosis* / Q000453:epidemiology* / Q000401:mortality; D015983:Selection Bias; D016019:Survival Analysis; D016896:Treatment Outcome; D016276:Ventricular Function
D015415:Biomarkers; D010446:Peptide Fragments; C109794:pro-brain natriuretic peptide (1-76); D020097:Natriuretic Peptide, Brain